Life Sciences
Digital therapeutics startup Dthera Sciences was sunk by Alzheimer's drug failures, CMS reimbursemen
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
According to FDA documents, the test is intended to help stop the spread of COVID-19 among Amazon employees.
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
The pilot study in north-east England will pioneer a personalised medicine approach.
The pair talk about the shift from traditional clinical trials based on drug research to digital innovations.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
Symmetric Health Solutions CEO Rich Kucera and Northern Light's Matt Marston discuss how COVID-19 has affected the supply chain as well as Northern Light's successful vaccine rollout.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
Along with the support of a Google Cloud-backed data platform, the partners will work to build and validate digital health programs for early intervention and engagement.
Moving from one-size-fits-all to personalized drug dosing can increase the efficacy and safety of medications, claims InsightRX CEO Sirj Goswami.